GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Aidigong Maternal & Child Health Ltd (HKSE:00286) » Definitions » ROE %

Aidigong Maternal & Child Health (HKSE:00286) ROE % : -37.21% (As of Dec. 2023)


View and export this data going back to 1990. Start your Free Trial

What is Aidigong Maternal & Child Health ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Aidigong Maternal & Child Health's annualized net income for the quarter that ended in Dec. 2023 was HK$-307.5 Mil. Aidigong Maternal & Child Health's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was HK$826.4 Mil. Therefore, Aidigong Maternal & Child Health's annualized ROE % for the quarter that ended in Dec. 2023 was -37.21%.

The historical rank and industry rank for Aidigong Maternal & Child Health's ROE % or its related term are showing as below:

HKSE:00286' s ROE % Range Over the Past 10 Years
Min: -40.65   Med: 0.43   Max: 8.65
Current: -20.8

During the past 13 years, Aidigong Maternal & Child Health's highest ROE % was 8.65%. The lowest was -40.65%. And the median was 0.43%.

HKSE:00286's ROE % is ranked worse than
78.69% of 610 companies
in the Healthcare Providers & Services industry
Industry Median: 4.32 vs HKSE:00286: -20.80

Aidigong Maternal & Child Health ROE % Historical Data

The historical data trend for Aidigong Maternal & Child Health's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aidigong Maternal & Child Health ROE % Chart

Aidigong Maternal & Child Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.84 -40.65 0.57 -16.50 -21.58

Aidigong Maternal & Child Health Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.32 -11.59 -21.49 -5.19 -37.21

Competitive Comparison of Aidigong Maternal & Child Health's ROE %

For the Medical Care Facilities subindustry, Aidigong Maternal & Child Health's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aidigong Maternal & Child Health's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Aidigong Maternal & Child Health's ROE % distribution charts can be found below:

* The bar in red indicates where Aidigong Maternal & Child Health's ROE % falls into.



Aidigong Maternal & Child Health ROE % Calculation

Aidigong Maternal & Child Health's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-177.421/( (906.753+737.702)/ 2 )
=-177.421/822.2275
=-21.58 %

Aidigong Maternal & Child Health's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Jun. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=-307.53/( (915.08+737.702)/ 2 )
=-307.53/826.391
=-37.21 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Aidigong Maternal & Child Health  (HKSE:00286) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-307.53/826.391
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-307.53 / 494.704)*(494.704 / 2072.2135)*(2072.2135 / 826.391)
=Net Margin %*Asset Turnover*Equity Multiplier
=-62.16 %*0.2387*2.5075
=ROA %*Equity Multiplier
=-14.84 %*2.5075
=-37.21 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-307.53/826.391
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-307.53 / -290.724) * (-290.724 / -277.6) * (-277.6 / 494.704) * (494.704 / 2072.2135) * (2072.2135 / 826.391)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.0578 * 1.0473 * -56.11 % * 0.2387 * 2.5075
=-37.21 %

Note: The net income data used here is two times the semi-annual (Dec. 2023) net income data. The Revenue data used here is two times the semi-annual (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Aidigong Maternal & Child Health ROE % Related Terms

Thank you for viewing the detailed overview of Aidigong Maternal & Child Health's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Aidigong Maternal & Child Health (HKSE:00286) Business Description

Traded in Other Exchanges
Address
1 Sheung Yuet Road, Unit E, 28th Floor, YHC Tower, Kowloon Bay, Kowloon, Hong Kong, HKG
Aidigong Maternal & Child Health Ltd is an investment holding company registered in Bermuda. It is active in health management and healthcare investment management business. The company provides life healthcare service, healthcare investment management business, natural health food business, advantage growth for children business. It is also engaged in investing and financing activities. The company manages its business in two reportable segments namely the health industry and Postpartum Care Services. It earns a majority of the revenue from the Postpartum Care Services. Geographically, it derives revenue from China.
Executives
Suntek Global Growth Fund Spc - Suntek Global Growth Fund Number One Sp 2102 Investment manager
Wang Aier 2305 Beneficiary of a trust
Cheung Wai Kuen 2201 Interest of corporation controlled by you
Champion Dynasty Limited 2101 Beneficial owner
Zhu Yufei 2101 Beneficial owner
Forever Heart Holdings Limited 2201 Interest of corporation controlled by you
Lee Kar Lung 2101 Beneficial owner
Zhuhai Deyou Bohui Enterprise Management Consulting Center (limited Partnership) 2101 Beneficial owner
Zhuhai Gao Ling Deyou Investment Management Co., Ltd. 2201 Interest of corporation controlled by you
Golden Full Holdings Limited 2106 Person having a security interest in shares

Aidigong Maternal & Child Health (HKSE:00286) Headlines

No Headlines